OPA1 mutation presenting as ethambutol-induced optic neuropathy

Key Points

• Optic neuropathy develops due to OPA1 mutation triggered by ethambutol, affecting vision.
• Notably, a 45-year-old male patient exhibited significant visual impairment after treatment with ethambutol.
• Case report detailing the genetic basis of optic neuropathy in response to ethambutol administration.
• Highlights the importance of genetic assessment in patients experiencing visual changes from drug exposure.